Gene · 8288
Papers2,629
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,629
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptomic Analysis of Genes Associated with Oxidative Stress in Chronic Rhinosinusitis Patients with Nasal Polyps: Identifying Novel Genes Involved in Nasal Polyposis. | Antioxidants (Basel) | 2022 | 36290622 | PubTator, text mining | PubMed |
| Allergic Rhinitis: Pathophysiology and Treatment Focusing on Mast Cells. | Biomedicines | 2022 | 36289748 | PubTator, text mining | PubMed |
| Thyroidal and Extrathyroidal Requirements for Iodine and Selenium: A Combined Evolutionary and (Patho)Physiological Approach. | Nutrients | 2022 | 36235539 | PubTator, text mining | PubMed |
| Allergic Inflammation: Effect of Propolis and Its Flavonoids. | Molecules | 2022 | 36235230 | PubTator, text mining | PubMed |
| Liver Graft Proteomics Reveals Potential Incipient Mechanisms behind Early Renal Dysfunction after Liver Transplantation. | Int J Mol Sci | 2022 | 36233231 | PubTator, text mining | PubMed |
| Multiple Timescale Dynamic Analysis of Functionally-Impairing Mutations in Human Ileal Bile Acid-Binding Protein. | Int J Mol Sci | 2022 | 36232642 | PubTator, text mining | PubMed |
| Tumor immune cell infiltration score based model predicts prognosis in multiple myeloma. | Sci Rep | 2022 | 36224246 | PubTator, text mining | PubMed |
| Targeting myeloid villains in the treatment with immune checkpoint inhibitors in gastrointestinal cancer. | Front Immunol | 2022 | 36211375 | PubTator, text mining | PubMed |
| Neutrophils in ANCA-associated vasculitis: Mechanisms and implications for management. | Front Pharmacol | 2022 | 36210838 | PubTator, text mining | PubMed |
| Probiotics, their action modality and the use of multi-omics in metamorphosis of commensal microbiota into target-based probiotics. | Front Nutr | 2022 | 36185680 | PubTator, text mining | PubMed |
| Human differentiated eosinophils release IL-13 in response to IL-33 stimulation. | Front Immunol | 2022 | 36177009 | PubTator, text mining | PubMed |
| Eosinophil Extracellular Traps Pave the Way for the Identification of Novel Therapeutics in Severe Asthma. | Allergy Asthma Immunol Res | 2022 | 36174987 | PubTator, text mining | PubMed |
| Improvement of Ulcerative Colitis by Aspartate via RIPK Pathway Modulation and Gut Microbiota Composition in Mice. | Nutrients | 2022 | 36145082 | PubTator, text mining | PubMed |
| Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma. | Biomedicines | 2022 | 36140282 | PubTator, text mining | PubMed |
| Enhancement of Nitric Oxide Bioavailability by Modulation of Cutaneous Nitric Oxide Stores. | Biomedicines | 2022 | 36140225 | PubTator, text mining | PubMed |
| Eosinophil Peroxidase Staining Enhances the Diagnostic Utility of the Cytosponge in Eosinophilic Esophagitis. | Clin Transl Gastroenterol | 2022 | 36137185 | PubTator, text mining | PubMed |
| Urinary total conjugated 3-bromotyrosine, asthma severity, and exacerbation risk. | Am J Physiol Lung Cell Mol Physiol | 2022 | 36126269 | PubTator, text mining | PubMed |
| A comprehensive insight into the anti-inflammatory properties of dapsone. | Naunyn Schmiedebergs Arch Pharmacol | 2022 | 36125533 | PubTator, text mining | PubMed |
| Serum Levels of Vascular Endothelial Growth Factor, Platelet Activating Factor and Eosinophil-Derived Neurotoxin in Chronic Spontaneous Urticaria-A Pilot Study in Adult Patients. | Int J Mol Sci | 2022 | 36077027 | PubTator, text mining | PubMed |
| Methamphetamine signals transcription of IL1β and TNFα in a reactive oxygen species-dependent manner and interacts with HIV-1 Tat to decrease antioxidant defense mechanisms. | Front Cell Neurosci | 2022 | 36060276 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8288/papers?page=17